Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Glioma was the most common type of intracranial malignant tumor. Even after standard treatment, the recurrence and malignant progression of lower-grade gliomas (LGGs) were almost inevitable. The overall survival (OS) of patients with LGG varied widely, making it critical for prognostic prediction. |

TÀI LIỆU LIÊN QUAN

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma

LINC00511 as a prognostic biomarker for human cancers: A systematic review and meta-analysis

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers

Long- term survival of women with breast cancer in biomarker context

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: A companion study to the PePiTA trial
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.